Literature DB >> 3007429

Effects of pheochromocytoma on cardiovascular alpha adrenergic receptor system.

G Tsujimoto, K Hashimoto, B B Hoffman.   

Abstract

We have examined the in vivo consequences of prolonged stimulation of the cardiovascular alpha-adrenergic receptor system in a rat model harboring pheochromocytoma. New England Deaconess Hospital rats with transplanted pheochromocytomas developed systolic hypertension and their plasma norepinephrine concentrations were approximately 60-fold greater than controls. Alpha 1-adrenergic receptors were quantitated in hearts from controls and rats with transplanted pheochromocytoma using the alpha 1-receptor selective antagonist [3H]prazosin. Down-regulation of alpha 1-receptors was found in the hearts of pheochromocytoma rats (33.0 vs. 23.0 fmol/mg protein) without any significant change in the affinities of these receptors for the circulating catecholamine, norepinephrine. Furthermore, the responsiveness of the blood vessel to the alpha-adrenergic stimulation was assessed using in vitro contractile experiments. Aortic rings from pheochromocytoma animals showed an eight fold decrease in sensitivity (EC50) and a 74% decrease in maximal contractility (Emax) to norepinephrine as compared with controls. Similarly, mesenteric artery rings prepared from the same animals showed a five fold loss of EC50 but no decrease in Emax to phenylephrine as compared with controls. In addition, serotonin EC50 and Emax of these mesentery preparations remained unaltered. Coupled with our previous findings [9], the present study suggests that rats with pheochromocytoma secreting large amounts of norepinephrine provide a valuable model system for studying in vivo desensitization of the cardiovascular alpha-receptor systems as well as the beta-adrenergic receptor system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3007429     DOI: 10.1007/bf02066410

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  31 in total

1.  Studies of a transplantable rat pheochromocytoma: biochemical characterization and catecholamine secretion.

Authors:  M Chalfie; R L Perlman
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

2.  Myocardial alpha adrenergic receptors and their role in the production of a positive inotropic effect by sympathomimetic agents.

Authors:  W C Govier
Journal:  J Pharmacol Exp Ther       Date:  1968-01       Impact factor: 4.030

3.  Stimulation by phenylephrine of adrenergic alpha- and beta-receptors in the isolated perfused rabbit heart.

Authors:  J Wagner; M Endoh; D Reinhardt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  Pheochromocytoma.

Authors:  S Warren; R N Chute
Journal:  Cancer       Date:  1972-02       Impact factor: 6.860

Review 5.  Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase.

Authors:  T K Harden
Journal:  Pharmacol Rev       Date:  1983-03       Impact factor: 25.468

6.  beta-Adrenergic receptor subtypes in the rat renal cortex. Selective regulation of beta 1-adrenergic receptors by pheochromocytoma.

Authors:  M D Snavely; H J Motulsky; E Moustafa; L C Mahan; P A Insel
Journal:  Circ Res       Date:  1982-10       Impact factor: 17.367

7.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

8.  Determination of plasma catecholamines and free 3,4-dihydroxyphenylacetic acid in continuously collected human plasma by high performance liquid chromatography with electrochemical detection.

Authors:  I N Mefford; M M Ward; L Miles; B Taylor; M A Chesney; D L Keegan; J D Barchas
Journal:  Life Sci       Date:  1981-02-02       Impact factor: 5.037

9.  Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications.

Authors:  E L Bravo; R C Tarazi; R W Gifford; B H Stewart
Journal:  N Engl J Med       Date:  1979-09-27       Impact factor: 91.245

10.  Vascular smooth muscle in hypertension.

Authors:  R J Winquist; R C Webb; D F Bohr
Journal:  Fed Proc       Date:  1982-06
View more
  3 in total

1.  Encapsulated pheochromocytoma cells secrete potent noncatecholamine factors.

Authors:  Hector R Mobine; George C Engelmayr; Nelson Moussazadeh; Tayyba R Anwar; Lisa E Freed; Elazer R Edelman
Journal:  Tissue Eng Part A       Date:  2009-07       Impact factor: 3.845

2.  Pheochromocytoma-induced cardiomyopathy is modulated by the synergistic effects of cell-secreted factors.

Authors:  Hector R Mobine; Aaron B Baker; Libin Wang; Hiroko Wakimoto; Kurt C Jacobsen; Christine E Seidman; J G Seidman; Elazer R Edelman
Journal:  Circ Heart Fail       Date:  2009-02-10       Impact factor: 8.790

3.  Profound bradycardia associated with NIV removal.

Authors:  C Echevarria; S C Bourke; G J Gibson
Journal:  Respir Med Case Rep       Date:  2011-11-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.